SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-320929
Filing Date
2019-12-20
Accepted
2019-12-20 16:17:30
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-3 d851821ds3.htm S-3 483860
2 EX-1.1 d851821dex11.htm EX-1.1 202561
3 EX-4.2 d851821dex42.htm EX-4.2 291798
4 EX-4.5 d851821dex45.htm EX-4.5 98628
5 EX-4.6 d851821dex46.htm EX-4.6 88769
6 EX-5.1 d851821dex51.htm EX-5.1 35350
7 EX-5.2 d851821dex52.htm EX-5.2 19965
8 EX-23.1 d851821dex231.htm EX-23.1 3160
9 GRAPHIC g851821cooley.jpg GRAPHIC 3248
10 GRAPHIC g851821g02d42.jpg GRAPHIC 15364
11 GRAPHIC g851821g50k23.jpg GRAPHIC 18697
12 GRAPHIC g851821g61b40.jpg GRAPHIC 57650
13 GRAPHIC g851821snap1.jpg GRAPHIC 10211
14 GRAPHIC g851821sp001.jpg GRAPHIC 2341
  Complete submission text file 0001193125-19-320929.txt   1373997
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235642 | Film No.: 191301699
SIC: 2834 Pharmaceutical Preparations